Volume 10, Number 11—November 2004
Research
Enhanced Identification of Postoperative Infections among Inpatients
Table 3
Sensitivity and positive predictive value of routine surveillance and screening by antimicrobial drug exposure, diagnosis codes, or both for identifying SSI after CABG procedures, cesarean delivery, and breast proceduresa
| Procedure/phase | Sensitivityb (%) |
Positive predictive valueb (%) |
|||||
|---|---|---|---|---|---|---|---|
| Routine surveillance | Antimicrobial exposure | Diagnosis code | Antimicrobial exposure and/or diagnosis code | Antimicrobial exposure | Diagnosis code | Antimicrobial exposure and/or diagnosis code | |
| CABG | |||||||
| Phase 1 | 79 | 80 | 61 | 87 | 33 | 86 | 35 |
| Phase 2 | 59 | 91 | 54 | 93 | 36 | 84 | 36 |
| Cesarean delivery | |||||||
| Phase 1 | 39 | 90 | 48 | 96 | 42 | 61 | 42 |
| Phase 2 | 38 | 84 | 78 | 97 | 37 | 67 | 38 |
| Breast procedures | |||||||
| Phase 1 | 71 | 71 | 50 | 79 | 19 | 58 | 20 |
| Phase 2 | 33 | 94 | 70 | 96 | 33 | 79 | 33 |
aSSI, surgical site infections; CABG, coronary artery bypass graft.
bCompared to standard criteria comprised of all infections identified during prospective surveillance or medical record review.


